logo
Select company
Select metric
$ 196.81MCore Assets
VS
Market
33
Sector
62
Industry
71
History
100
$ 10.8Close
$ 6.56 - $ 12.79 52-Week Range
Ticker Information

Ticker

ZVRA

Company Name

ZEVRA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZEVRA THERAPEUTICS INC - Core Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZVRA - Core Assets Historical data
DateTotal AssetsCash and EquivalentsCore AssetsGoodwill and Intangibles
6/30/2025$ 256.28M$ 47.71M$ 196.81M$ 11.75M
3/31/2025$ 172.71M$ 37.34M$ 63.29M$ 72.08M
12/31/2024$ 178.13M$ 33.78M$ 70.65M$ 73.69M
9/30/2024$ 191.55M$ 54.04M$ 62.2M$ 75.31M
6/30/2024$ 144.41M$ 39.26M$ 34.29M$ 70.86M
3/31/2024$ 151.28M$ 42.85M$ 36.03M$ 72.4M
12/31/2023$ 172.33M$ 43.05M$ 55.35M$ 73.93M
9/30/2023$ 138.98M$ 43.27M$ 95.71M$ 0
6/30/2023$ 105.52M$ 66.2M$ 39.32M$ 0
3/31/2023$ 106.59M$ 40.18M$ 66.41M$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZEVRA THERAPEUTICS INC's latest trailing twelve months (TTM) Core Assets stands at $ 5.75M.
  • Over the past 5 years, ZEVRA THERAPEUTICS INC's average Core Assets has been $ 47.62M.
  • The median Core Assets for ZEVRA THERAPEUTICS INC during this period was $ 43.4M
  • ZEVRA THERAPEUTICS INC reached its highest Core Assets over the past 5 years at $ 196.81M.
  • The lowest Core Assets recorded by ZEVRA THERAPEUTICS INC in the same timeframe $ 5.68M

ZEVRA THERAPEUTICS INC's Core Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Core Assets Benchmarks
CompanyCore Assets
EYPT : EYEPOINT PHARMACEUTICALS INC $ 229.85MTBPH : THERAVANCE BIOPHARMA INC $ 143.27MSAGE : SAGE THERAPEUTICS INC $ 353.99MMGTX : MEIRAGTX HOLDINGS PLC $ 163.55MLXRX : LEXICON PHARMACEUTICALS INC $ 130.68MNKTR : NEKTAR THERAPEUTICS $ 164.55MKURA : KURA ONCOLOGY INC $ 600.48MGOSS : GOSSAMER BIO INC $ 214.62MNRIX : NURIX THERAPEUTICS INC $ 443.07MSNDX : SYNDAX PHARMACEUTICALS INC $ 487.3M

Definition of Core Assets

[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for ZEVRA THERAPEUTICS INC is calculated as follows: Assets [ $ 11.2M ] - Intangibles [ $ 0 ] - CashnEq [ $ 5.45M ]
(=) Core Assets [ $ 5.75M ]

ZVRA - Core Assets, Last 5 years

$ 5.68M

Minimum

Sep 30, 2021

$ 196.81M

Maximum

Jun 30, 2025

$ 47.62M

Average

$ 43.4M

Median

Core Assets Benchmark Analysis

The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 798.36M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
filtered constituents3.42K
min$ 0
max$ 4.36B
average$ 798.36M
median$ 287.51M
std$ 1.05B